Tenon Medical, Inc. (TNONW) income statement

TNONWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as TNON

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 9/30

$0.00−0.00 (-36.17%)

Close on Oct 30, 2026Market cap $1.37MP/E –Yield –

Tenon Medical, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	3.94	3.28	2.93	0.69	0.16
Cost of Revenue	1.59	1.57	1.69	1.33	0.06
Gross Profit	2.36	1.71	1.24	-0.64	0.11
Research & Development	2.15	2.60	3.16	2.83	1.72
Selling, General & Admin	13	13	14	15	4.85
Selling & Marketing	6.03	5.11	6.78	7.83	2.14
General & Administrative	6.98	7.77	7.03	7.42	2.71
Operating Expenses	15	15	17	18	6.57
Operating Income	-13	-14	-16	-19	-6.46
Interest Expense	–	0.03	0.02	0.35	0.62
Other Non-Operating Income	0.24	0.09	0.15	-0.19	-0.62
Gain (Loss) on Investments	0.24	0.18	0.17	0.18	0.00
Gain (Loss) on Sale of Assets	–	–	–	-0.08	0
Pretax Income	–	–	–	-19	-7.08
Income from Continuing Operations	-13	-14	-16	-19	–
Net Income incl. Noncontrolling Interests	–	–	–	-19	-7.08
Minority Interest in Earnings	–	–	–	0	-0.03
Net Income	-13	-14	-16	-19	-7.05
EPS (Basic)(per share)	-59.50	-394.10	-2,402.40	-6,613.60	-21,868.00
EPS (Diluted)(per share)	-59.50	-394.10	-2,402.40	-6,613.60	-21,868.00
Shares Outstanding (Basic, Weighted)(shares)	0.00	0.00	0.00	0.00	0
Shares Outstanding (Diluted, Weighted)(shares)	0.00	0.00	0.00	0.00	0
EBITDA	-13	-13	-16	-19	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 66.8%
Operating margin: -242.7%
Net margin: -257.9%
Return on equity, FY2025: -228.1%

Financial strength

Current ratio: 0.58
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 20.2%

Valuation

P/E ratio: –
Price to sales: 0.26
Price to book: –
Dividend yield: –